Disclosed are methods of identifying subjects with Diabetes or a
pre-diabetic condition, methods of identifying subjects at risk for
developing Diabetes or a pre-diabetic condition, methods of
differentially diagnosing diseases associated with Diabetes or a
pre-diabetic condition from other diseases or within sub-classifications
of Diabetes, methods of evaluating the risk of progression to Diabetes or
a pre-diabetic condition in patients, methods of evaluating the
effectiveness of treatments in subjects with Diabetes or a pre-diabetic
condition, and methods of selecting therapies for treating Diabetes or a
pre-diabetic condition, using biomarkers.